Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ASTRAZENECA PHARMA AJANTA PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 22.8 111.2 20.5% View Chart
P/BV x 5.0 15.6 31.9% View Chart
Dividend Yield % 0.7 0.3 238.3%  

Financials

 AJANTA PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
ASTRAZENECA PHARMA
Mar-22
AJANTA PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6144,580 35.2%   
Low Rs1,0892,529 43.0%   
Sales per share (Unadj.) Rs391.1322.2 121.4%  
Earnings per share (Unadj.) Rs83.424.6 338.6%  
Cash flow per share (Unadj.) Rs98.131.4 312.2%  
Dividends per share (Unadj.) Rs9.5010.00 95.0%  
Avg Dividend yield %0.70.3 249.9%  
Book value per share (Unadj.) Rs382.1203.8 187.5%  
Shares outstanding (eoy) m85.4225.00 341.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.511.0 31.3%   
Avg P/E ratio x16.2144.3 11.2%  
P/CF ratio (eoy) x13.8113.1 12.2%  
Price / Book Value ratio x3.517.4 20.3%  
Dividend payout %11.440.6 28.1%   
Avg Mkt Cap Rs m115,43388,863 129.9%   
No. of employees `000NANA-   
Total wages/salary Rs m6,4582,302 280.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,4108,056 414.7%  
Other income Rs m1,157148 783.7%   
Total revenues Rs m34,5678,204 421.4%   
Gross profit Rs m9,293862 1,078.3%  
Depreciation Rs m1,253170 739.2%   
Interest Rs m10210 1,073.7%   
Profit before tax Rs m9,095830 1,095.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,968214 917.9%   
Profit after tax Rs m7,127616 1,156.9%  
Gross profit margin %27.810.7 260.0%  
Effective tax rate %21.625.8 83.8%   
Net profit margin %21.37.6 279.0%  
BALANCE SHEET DATA
Current assets Rs m24,5487,653 320.8%   
Current liabilities Rs m8,3773,923 213.5%   
Net working cap to sales %48.446.3 104.5%  
Current ratio x2.92.0 150.2%  
Inventory Days Days4261 68.2%  
Debtors Days Days1139 28.6%  
Net fixed assets Rs m19,2592,120 908.4%   
Share capital Rs m17250 343.4%   
"Free" reserves Rs m32,4695,044 643.7%   
Net worth Rs m32,6405,094 640.7%   
Long term debt Rs m160-   
Total assets Rs m43,8079,773 448.2%  
Interest coverage x90.288.4 102.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 92.5%   
Return on assets %16.56.4 257.8%  
Return on equity %21.812.1 180.6%  
Return on capital %28.216.5 170.8%  
Exports to sales %00-   
Imports to sales %031.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA2,552 0.0%   
Fx inflow Rs m18,678442 4,225.8%   
Fx outflow Rs m3,6622,552 143.5%   
Net fx Rs m15,016-2,110 -711.7%   
CASH FLOW
From Operations Rs m5,6201,008 557.6%  
From Investments Rs m-74147 -1,563.3%  
From Financial Activity Rs m-4,600-95 4,863.0%  
Net Cashflow Rs m279961 29.0%  

Share Holding

Indian Promoters % 70.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 21.2 3.8 561.1%  
FIIs % 8.3 2.5 334.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 25.0 118.1%  
Shareholders   64,445 53,980 119.4%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    LUPIN    


More on AJANTA PHARMA vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs ASTRAZENECA PHARMA Share Price Performance

Period AJANTA PHARMA ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day -0.34% -1.90% -0.46%
1-Month -2.07% 4.58% 0.65%
1-Year -12.98% 2.61% -13.70%
3-Year CAGR 22.65% 15.07% 20.93%
5-Year CAGR 9.81% 28.27% 10.98%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

ASTRAZENECA PHARMA paid Rs 10.0, and its dividend payout ratio stood at 40.6%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.